Cellectar Biosciences(CLRB)
FLORHAM PARK, NJBiotechnology
Focus: Cellectar is a public-stage biotechnology company developing small-molecule therapeutics primarily in oncology and infectious diseases. The company operates at a modest scale with a highly experimental pipeline focused on radiopharmaceuticals and novel small molecules.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Cellectar Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Cellectar Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Peak
Only Phase 3 program in pipeline, represents most advanced clinical development stage but generic formulation limits differentiation.
Pipeline & Clinical Trials
Help build intelligence for Cellectar Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.